Bordeaux area (FR), June 2016 – MEMOPHENOLTM has been awarded at the French Innovation Corner in the category of Pharmaceutical Products at the last Vitafoods Europe show. MEMOPHENOLTM has been recognized for its innovation and international resonance among 15 shortlisted products by Nutrimarketing and Bpifrance Innovation. Developed by ACTIV’INSIDE, following a 4-years French-Canadian international research program involving 10 academic and industrial partners, MEMOPHENOLTM combines highly bioavailable French grape (Vitis vinifera) and wild Canadian blueberry (Vaccinium angustifolium) extracts, whose synergistic action is patented. This award also recognizes the R&D approach at the origin of the important scientific background supporting the effectiveness of MEMOPHENOL™. The improvement of cognitive functions, especially learning and memory, has been clinically proven. Suitable for a wide audience, from student to senior, the solution MEMOPHENOL™ provides a body of scientific evidence and differentiating elements, ensuring product credibility and consumer loyalty.
FOCUS ON THE FRENCH INNOVATION CORNER
Launched for the first time at the Vitafoods Europe show by Business France, the French Innovation Corner contest has honored company’s manufacturers of functional ingredients. 15 products were shortlisted by Bpifrance Innovation and Nutrimarketing for their innovation and by Business France for their international potential, and displayed on the French Innovation Corner booth at the pavilion France. Developed by ACTIV’INSIDE, MEMOPHENOLTM has been honored in the category Pharmaceutical Products.
« This award recognizes the 4 years of research undertaken in the framework of the French-Canadian project NEUROPHENOLS® », highlights David GAUDOUT, Chief Innovation Officer at ACTIV’INSIDE. “Whether in the field of chemistry and biology of polyphenols, in neuroscience, or in the engineering of nutritional active ingredients, the synergy of expertise of the various project stakeholders contributed to the development of MEMOPHENOLTM. This cross innovation based on science is today recognized through this award” adds David GAUDOUT.